HAUS4 is a subunit of the human augmin complex, essential for microtubule branching during mitosis. Key biological features include:
HAUS4 exists in four isoforms with molecular weights of 27–29 kDa, 37 kDa, and 42 kDa, detectable across species including humans, mice, and rats .
The HAUS4 antibody (e.g., 20104-1-AP from Proteintech) is a rabbit-derived IgG polyclonal antibody validated for multiple applications:
The HAUS4 antibody has been instrumental in advancing studies on mitotic mechanisms:
Microtubule Branching: Demonstrated HAUS4’s role in reconstituting human microtubule branching machinery, critical for spindle assembly .
Acentrosomal Spindle Assembly: Revealed HAUS4’s necessity in acentrosomal spindle formation in human oocytes, highlighting its evolutionary conservation .
Parenchymal vs. Vascular Localization: HAUS4 antibodies effectively distinguish spindle-associated HAUS4 in mitotic cells from cytoplasmic pools .
Cross-Species Utility: Consistent detection in human, mouse, and rat models supports translational research .
HAUS4 (also known as C14orf94) is a subunit of the centrosome complex termed the human augmin complex. This protein localizes to spindle microtubules and plays crucial roles in mitotic spindle assembly, maintenance of centrosome integrity during cell division, and completion of cytokinesis . HAUS4 is part of an 8-subunit complex (HAUS1-8) that functions in microtubule-dependent amplification of centrosomes . Studying HAUS4 is significant for understanding fundamental cellular processes related to mitosis and chromosomal stability, which have implications in cancer research and cell biology.
For optimal Western blot detection of HAUS4:
Sample preparation: Use tissues with known HAUS4 expression (brain, placenta, lung, skin)
Protein loading: 20-30 μg of total protein is typically sufficient
Antibody dilution: Use 1:1000-1:4000 dilution for primary antibody
Molecular weight expectation: Be prepared to detect bands at multiple molecular weights (28 kDa, 37 kDa, 42 kDa) due to different isoforms
Blocking: 5% non-fat milk in TBST for 1 hour at room temperature
Incubation: Overnight at 4°C for primary antibody followed by appropriate secondary antibody
Detection method: Enhanced chemiluminescence (ECL) is suitable
For troubleshooting, note that small volumes of antibody may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial to dislodge any liquid in the container's cap .
For optimal immunohistochemistry detection of HAUS4:
Antigen retrieval: Use TE buffer pH 9.0 (alternatively, citrate buffer pH 6.0)
Tissue selection: HAUS4 antibodies have been validated on human prostate cancer tissue, human colon cancer tissue, and human placenta tissue
Incubation conditions: Typically overnight at 4°C
Detection system: Use a polymer-based detection system for enhanced sensitivity
Controls: Include positive tissues (placenta, skin) and negative controls (antibody diluent only)
Signal amplification: Consider tyramide signal amplification for low-expressing samples
Each new tissue type may require optimization of antigen retrieval conditions and antibody concentration.
To verify specificity and address non-specific binding:
Peptide competition assay: Pre-incubate the antibody with the immunogen peptide before application to block specific binding
HAUS4 knockdown/knockout controls: Use CRISPR-edited cells with HAUS4 knockout as negative controls
Multiple antibody validation: Test different HAUS4 antibodies targeting different epitopes
Cross-reactivity testing: Check binding in samples known to lack HAUS4 expression
Blocking optimization: Test different blocking agents (BSA, normal serum, commercial blockers)
Antibody titration: Perform a dilution series to find the optimal concentration that maximizes specific signal while minimizing background
Secondary antibody controls: Include controls with only secondary antibody to identify non-specific binding
For reproducibility, always document lot numbers and validation data of antibodies used.
Common pitfalls and their solutions:
Molecular weight discrepancies:
Subcellular localization variability:
Fixation sensitivity:
Pitfall: Some epitopes may be sensitive to particular fixatives
Solution: Compare different fixation methods (PFA, methanol, acetone)
Antibody specificity issues:
Storage and handling:
To study HAUS4 interactions within the augmin complex:
Lysis buffer optimization:
Use gentle lysis buffers (e.g., 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% Triton X-100)
Include protease and phosphatase inhibitors
For microtubule-associated proteins, consider adding stabilizing agents like taxol
Antibody selection:
Choose antibodies with demonstrated IP capability
Consider epitope-tagged HAUS4 constructs if antibody IP efficiency is low
Co-IP protocol:
Pre-clear lysates with protein A/G beads
Incubate with HAUS4 antibody overnight at 4°C
Capture with protein A/G beads for 2-3 hours
Wash extensively (at least 4-5 times)
Elute using either low pH, high pH, or SDS sample buffer
Controls:
Include IgG control
Include input fraction (5-10% of starting material)
Consider reciprocal IP with antibodies against known HAUS complex members
Analysis:
Advanced imaging techniques for HAUS4 dynamics:
Super-resolution microscopy (SRM):
Structured Illumination Microscopy (SIM): Provides 2x resolution improvement
Stimulated Emission Depletion (STED): For visualizing fine HAUS4 distribution at centrosomes
Photoactivated Localization Microscopy (PALM)/Stochastic Optical Reconstruction Microscopy (STORM): For single-molecule level resolution
Live-cell imaging:
Generate fluorescent protein-tagged HAUS4 constructs (e.g., GFP-HAUS4)
Use spinning disk confocal microscopy for reduced phototoxicity
Consider lattice light-sheet microscopy for highest temporal resolution
Multi-color imaging:
Co-label with markers for:
Centrosomes (γ-tubulin, pericentrin)
Microtubules (α-tubulin)
Chromosomes (DAPI, H2B-GFP)
Cell cycle markers (PCNA, cyclin B)
Fluorescence Recovery After Photobleaching (FRAP):
Measure HAUS4 dynamics at the mitotic spindle
Determine exchange rates and stable vs. mobile fractions
Expansion microscopy:
Physical expansion of samples can provide increased resolution with standard confocal microscopy
Particularly useful for crowded structures like centrosomes
To correctly interpret HAUS4 staining patterns:
Cell cycle-dependent localization:
Co-localization analysis:
With centrosome markers (γ-tubulin, pericentrin): Should show partial overlap
With microtubule markers (α-tubulin): Should show strong co-localization along spindle fibers
With kinetochore markers: May show proximity but not direct co-localization
Quantitative assessment:
Measure HAUS4 signal intensity at centrosomes across cell cycle stages
Assess spindle-associated HAUS4 vs. cytoplasmic HAUS4 ratio
Abnormal patterns:
Diffuse cytoplasmic staining: May indicate inactive protein or antibody issues
Asymmetric centrosomal staining: Could indicate centrosome abnormalities
Nuclear staining: Likely non-specific unless validated
Distinguishing isoforms:
To study functional relationships between HAUS4 and other centrosomal components:
Genetic perturbation approaches:
Interaction mapping:
Proximity ligation assay (PLA) to detect protein-protein interactions in situ
BioID or TurboID proximity labeling to identify proximity interactions
FRET/FLIM for direct interaction detection in live cells
Functional readouts:
Spindle morphology (bipolar vs. multipolar spindles)
Microtubule nucleation assays
Centrosome integrity (measured by centrosome marker intensity)
Mitotic timing and progression (measured by live-cell imaging)
Chromosome segregation fidelity (measured by aneuploidy rates)
Biochemical reconstitution:
In vitro reconstitution of partial or complete HAUS complex
Microtubule binding and bundling assays
Microtubule nucleation assays with purified components
Electron microscopy:
Immune-electron microscopy to determine precise localization
Correlative light and electron microscopy (CLEM) to combine functional data with ultrastructural information
Different fixation methods impact HAUS4 antibody staining:
Always perform side-by-side comparisons with multiple fixation methods when establishing protocols for a new cell type.
When facing conflicting HAUS4 antibody results:
Antibody validation reassessment:
Technical parameters examination:
Biological variation sources:
Cell line differences (transformed vs. primary cells)
Tissue-specific isoform expression
Cellular stress conditions
Cell density and culture conditions
Data integration approaches:
Perform meta-analysis of published results
Contact authors of conflicting papers for protocols
Combine multiple detection methods (IF, IP-Western, live imaging)
Quantitative analysis rather than qualitative assessment
Reporting conflicts transparently:
Document all experimental conditions
Present both your data and the conflicting published data
Propose biological or technical explanations for discrepancies
Consider cell/tissue-specific regulation may explain differences
By systematically evaluating these factors, you can determine whether conflicts arise from technical issues or represent genuine biological differences worth further investigation.